Response to olaparib in metastatic castration-resistant prostate cancer with germline BRCA2 mutation: a case report

Overview of attention for article published in BMC Medical Genomics, October 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 38 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 8 publications that cite this research output.

8

The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.

A Case-Based Clinical Approach to the Investigation, Management and Screening of Families with BRCA2 Related Prostate Cancer

Article in The Application of Clinical Genetics (May 2021)

Patient-derived xenografts and organoids model therapy response in prostate cancer

Article in Nature Communications (February 2021)

International experience of using olaparib for metastatic castration-resistant prostate cancer: literature review

Article in Cancer Urology (February 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.